David Wohlpart, PhD Merck & Co.

Dave Wohlpart has been with Merck & Co. since 1990 after completing a PhD in Biochemical Engineering from the University of Virginia. In his 30 years at Merck, he has been involved in vaccines manufacturing in various capacities, and has extensive experience in recombinant protein manufacturing technology, including Operations Technical Support; Technology Transfer; Process Development; Process & Facility Design, Startup, Validation, and Licensure; Regulatory Inspections and other Health Authority interactions; and Project Leadership/Management. In his current role, Dave is responsible for the global technology support for Merck’s HPV Vaccines Franchise.